Haemoglobinopathies congenital Terminated Phase 2 Trials for Prednisone (DB00635)

Also known as: Haemoglobinopathies / Haemoglobinopathy / Hemoglobinopathy / Hemoglobinopathies / Haemoglobinopathy NOS / Abnormal hemoglobin NOS

IndicationStatusPhase
DBCOND0026458 (Haemoglobinopathies congenital)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00034528Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaTreatment